Evidence map›Paper›PMID 33133446›Full record

ArticleJournal of ophthalmic & vision research

Photodynamic Therapy in Ocular Oncology.

Mehdi Mazloumi, Lauren A Dalvin, Seyed-Hossein Abtahi, Negin Yavari, Antonio Yaghy, Arman Mashayekhi, Jerry A Shields, Carol L Shields

Open access · goldAbstract read
In one paragraph

Article in Journal of ophthalmic & vision research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Ring-FusedFrontiers in chemistry · 2022
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Mehdi MazloumiOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, USA.
Lauren A DalvinDepartment of Ophthalmology, Mayo Clinic, Rochester, USA.
Seyed-Hossein AbtahiIsfahan Eye Research Center, Feiz Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Negin YavariDepartment of Cardiovascular Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Antonio YaghyOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, USA.
Arman MashayekhiOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, USA.
Jerry A ShieldsOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, USA.
Carol L ShieldsOcular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, USA.
Wills Eye Hospital · USThomas Jefferson University · USIsfahan University of Medical Sciences · IRMayo Clinic · USTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past two decades, we have witnessed the increasing use of photodynamic therapy (PDT) in the field of ocular oncology. Based on a review of the literature and our own experience, we herein review the role of PDT for the management of intraocular tumors. The discussion includes two main topics. First, we discuss the application of PDT for benign tumors, including circumscribed choroidal hemangioma, choroidal osteoma, retinal astrocytoma, retinal capillary hemangioma (retinal hemangioblastoma), and retinal vasoproliferative tumor. Second, we assess the role of PDT for malignant tumors, including choroidal melanoma and choroidal metastasis.

Indexed as

Choroid; EyeHemangiomaMelanomaMetastasisPhotodynamic therapy RetinaTumor

Identifiers

PMID33133446
PMCPMC7591845
OpenAlexW3094572289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.